Related Experiment Video
Updated: Jun 28, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Oh my aching gut: irritable bowel syndrome, Blastocystis, and asymptomatic infection
Kenneth F Boorom1, Huw Smith, Laila Nimri
1Blastocystis Research Foundation, 5060 SW Philomath Blvd, #202, Corvallis, OR 97333, USA. director@bhomcenter.org.
Abstract:
Blastocystis is a prevalent enteric protozoan that infects a variety of vertebrates. Infection with Blastocystis in humans has been associated with abdominal pain, diarrhea, constipation, fatigue, skin rash, and other symptoms. Researchers using different methods and examining different patient groups have reported asymptomatic infection, acute symptomatic infection, and chronic symptomatic infection. The variation in accounts has lead to disagreements concerning the role of Blastocystis in human disease, and the importance of treating it. A better understanding of the number of species of Blastocystis that can infect humans, along with realization of the limitations of the existing clinical laboratory diagnostic techniques may account for much of the disagreement. The possibility that disagreement was caused by the emergence of particular pathogenic variants of Blastocystis is discussed, along with the potential role of Blastocystis infection in irritable bowel syndrome (IBS). Findings are discussed concerning the role of protease-activated receptor-2 in enteric disease which may account for the presence of abdominal pain and diffuse symptoms in Blastocystis infection, even in the absence of fever and endoscopic findings. The availability of better diagnostic techniques and treatments for Blastocystis infection may be of value in understanding chronic gastrointestinal illness of unknown etiology.
Insights
Blastocystis, a common gut microbe, causes varied symptoms like diarrhea and fatigue. Disagreements on its role in human disease highlight the need for better diagnostics and understanding of pathogenic variants.
Area of Science:
- Medical Parasitology
- Gastroenterology
- Microbiology
Background:
- Blastocystis is a widespread enteric protozoan infecting humans and animals.
- Human Blastocystis infections present with diverse symptoms, including abdominal pain, diarrhea, and fatigue.
- Conflicting reports on Blastocystis's pathogenicity contribute to debates regarding its clinical significance and treatment.
Purpose of the Study:
- To explore the reasons behind the disagreement on Blastocystis's role in human disease.
- To discuss the impact of Blastocystis species diversity and diagnostic limitations on clinical interpretation.
- To investigate the potential role of pathogenic Blastocystis variants and their link to irritable bowel syndrome (IBS).
Main Methods:
- Review of existing literature on Blastocystis infections in humans.
- Analysis of factors contributing to varied clinical presentations and diagnostic challenges.
- Discussion of emerging research on pathogenic variants and host-pathogen interactions.
Main Results:
- The diversity of Blastocystis species and limitations in current diagnostic methods contribute to conflicting clinical observations.
- Specific pathogenic variants of Blastocystis may be responsible for symptomatic infections.
- Protease-activated receptor-2 signaling is implicated in Blastocystis-associated abdominal pain and diffuse symptoms.
Conclusions:
- Improved diagnostic techniques and a deeper understanding of Blastocystis species are crucial for resolving clinical disagreements.
- Further research into pathogenic variants and their mechanisms, such as protease-activated receptor-2 pathways, is warranted.
- Better diagnostics and treatments for Blastocystis could aid in managing chronic gastrointestinal disorders of unknown origin.
Related Concept Videos
Irritable Bowel Syndrome
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Giardiasis
Amebiasis
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Inflammatory Bowel Disease I: Introduction
